Drug intelligence / Profile preview

Huashi Tongbi Formula

Development stage: Preclinical
Lead developer: The King's Fund
Administration: Oral

Overview

Huashi Tongbi Formula is a Chinese herbal compound developed for the treatment of erectile dysfunction, specifically in patients presenting with a "damp heat affecting Pi (Spleen) pattern". It is administered orally, typically as granules or a liquid preparation. Research is ongoing to evaluate its efficacy and safety, and to explore its potential mechanisms of action, including its impact on gut microbiota.

Other names: HTF

Beyond the preview

Go deeper on Huashi Tongbi Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huashi Tongbi Formula.

Explore the full profile